Interprofessionnal collaboration in the ICU: pharmacists’ integration for over 10 years
Details
Serval ID
serval:BIB_7679C2595082
Type
Inproceedings: an article in a conference proceedings.
Publication sub-type
Poster: Summary – with images – on one page of the results of a researche project. The summaries of the poster must be entered in "Abstract" and not "Poster".
Collection
Publications
Institution
Title
Interprofessionnal collaboration in the ICU: pharmacists’ integration for over 10 years
Title of the conference
Jahrestagung der Schweizerischen Gesellschaft für Intensivmedizin (SGI)
Address
Lausanne (Switzerland), September 18-20, 2024
Publication state
Published
Issued date
2024
Peer-reviewed
Oui
Language
english
Abstract
Background: ICU patients are prescribed high numbers of medications, twice as many as those in other hospital departments. Medication management can be challenging considering the many types of medications used (high risk medications) and patient’s specific medical conditions.
Objective: Describe the close interprofessional collaboration between the unit’s dedicated clinical pharmacists and its medical and nursing staff in a regional hospital’s ICU (8 critical care and 10 intermediate care beds)
Method: A qualitative and quantitative description of the various activities involving clinical pharmacists and their evolution over the last decade.
Results: In 2023, two clinical pharmacists (0.35 FTE) were dedicated to the ICU and performed various activities:
- Medication optimisation during clinical rounds. Clinical pharmacists took part in 78 clinical rounds in 2023, a significant increase from 35 in 2012 and 67 in 2022. Based on data from 2020–2022, the three most frequent interventions were dealing with medication side effects, medication overuse/duplicate therapies, and medication warnings. The mean number of pharmaceutical interventions per patient was 2.21, and 94% of suggestions were accepted.
- Pharmaceutical information center: clinical pharmacists answered 156 questions related to medications in 2023, a number that increased from 103 in 2012 to 186 in 2022. Based on data from 2020–2022, questions involved drug administration, IV compatibility, alternative medications, obtention, side effects and medication dosage.
- Pharmaceutical support. Clinical pharmacists managed more than 80 documents and protocols in 2023 and made them available to the ICU team. These included administration protocols, IV compatibility tables, therapeutic class comparison tables and good practice recommendations.
- Patient safety. Clinical pharmacists took part in various projects ensuring medication safety, such as ICU injectable drug labelling (n = 126 ICU-specific labels), setting up the IV library of 93 medications prepared and validated, drug incident analysis, including morbidity and mortality reviews, and room of errors for medical and nursing training.
Conclusion: A variety of activities involving clinical pharmacists have been implemented in our ICU over the last 10 years. Clinical pharmacists are integral members of the ICU’s interprofessional team, ensuring medication safety at various points in the medication circuit and, therefore, the quality of care.
Objective: Describe the close interprofessional collaboration between the unit’s dedicated clinical pharmacists and its medical and nursing staff in a regional hospital’s ICU (8 critical care and 10 intermediate care beds)
Method: A qualitative and quantitative description of the various activities involving clinical pharmacists and their evolution over the last decade.
Results: In 2023, two clinical pharmacists (0.35 FTE) were dedicated to the ICU and performed various activities:
- Medication optimisation during clinical rounds. Clinical pharmacists took part in 78 clinical rounds in 2023, a significant increase from 35 in 2012 and 67 in 2022. Based on data from 2020–2022, the three most frequent interventions were dealing with medication side effects, medication overuse/duplicate therapies, and medication warnings. The mean number of pharmaceutical interventions per patient was 2.21, and 94% of suggestions were accepted.
- Pharmaceutical information center: clinical pharmacists answered 156 questions related to medications in 2023, a number that increased from 103 in 2012 to 186 in 2022. Based on data from 2020–2022, questions involved drug administration, IV compatibility, alternative medications, obtention, side effects and medication dosage.
- Pharmaceutical support. Clinical pharmacists managed more than 80 documents and protocols in 2023 and made them available to the ICU team. These included administration protocols, IV compatibility tables, therapeutic class comparison tables and good practice recommendations.
- Patient safety. Clinical pharmacists took part in various projects ensuring medication safety, such as ICU injectable drug labelling (n = 126 ICU-specific labels), setting up the IV library of 93 medications prepared and validated, drug incident analysis, including morbidity and mortality reviews, and room of errors for medical and nursing training.
Conclusion: A variety of activities involving clinical pharmacists have been implemented in our ICU over the last 10 years. Clinical pharmacists are integral members of the ICU’s interprofessional team, ensuring medication safety at various points in the medication circuit and, therefore, the quality of care.
Create date
11/07/2024 12:04
Last modification date
19/01/2025 0:02